Search Results - "Zhu, Hanzhang"
-
1
CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
Published in International journal of molecular sciences (11-10-2022)“…Pancreatic cancer is one of the most lethal malignant tumors. However, the molecular mechanisms responsible for its progression are little known. This study…”
Get full text
Journal Article -
2
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
Published in Cellular physiology and biochemistry (01-01-2018)“…Background/Aims: The expression of PRAME and its role in hepatocellular carcinoma (HCC) remain unknown. The aim of this study was to examine the functional…”
Get full text
Journal Article -
3
Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease
Published in Gut and liver (01-07-2020)“…Background/AimsThe pathogenesis of nonalcoholic fatty liver disease (NAFLD) has not be fully elucidated, and the lack of therapeutic strategies for NAFLD is an…”
Get full text
Journal Article -
4
Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy
Published in Cancer nanotechnology (01-12-2020)“…Background The present study aims to develop a nanoparticle encapsulating doxorubicin (DOX) and programmed death-ligand 1 (PD-L1) siRNA and evaluate its…”
Get full text
Journal Article -
5
Resveratrol protects against chronic alcohol-induced liver disease in a rat model
Published in STEMedicine (02-07-2022)“…Hepatic ethanol metabolism participates in the pathogenesis of alcoholic liver disease (ALD). We aimed to evaluate the protecting effects and underlying…”
Get full text
Journal Article -
6
Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN
Published in Cellular physiology and biochemistry (01-01-2017)“…Background & Aims: To investigate the expression and prognostic value of α1-ACT (Alpha1-antichymotrypsin) in patients with HCC (hepatocellular carcinoma) and…”
Get full text
Journal Article -
7
Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine-Related lncRNAs Profiling
Published in Frontiers in molecular biosciences (04-02-2022)“…HCC is one of the most common types of malignancies worldwide and the fourth-leading cause of cancer deaths. Thus, there is an urgent need to search for novel…”
Get full text
Journal Article -
8
Selective radical resection for unresectable pancreatic cancer
Published in Cirugia y cirujanos (01-04-2022)“…The objective of the study was to evaluate safety and value of radical resection for unresectable pancreatic cancer (UPC). Clinical data were analyzed…”
Get full text
Journal Article -
9
Selective Radical Resection for Unresectable Pancreatic Cancer
Published in BioMedica (31-12-2020)“…Background and Objective: For inefficiency of chemotherapy and radiation against pancreatic cancer, resection rate for primary unresectable pancreatic cancer…”
Get full text
Journal Article -
10
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
Published in Cellular oncology (Dordrecht) (01-12-2020)“…Background Hepatocellular carcinoma (HCC) is one of the most common and devastating malignancies. Oxaliplatin, a platinum-based chemotherapeutic agent, is…”
Get full text
Journal Article -
11
miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling
Published in Aging (Albany, NY.) (26-12-2021)“…In this study, we examined whether and how miR-545 modulates ferroptosis in colorectal cancer (CRC). HT-29 and HCT-116 human CRC cell viability was examined…”
Get full text
Journal Article -
12
Selective Radical Resection for Unresectable Pancreatic Cancer
Published in BioMedica (31-12-2020)“…Background and Objective: For inefficiency of chemotherapy and radiation against pancreatic cancer, resection rate for primary unresectable pancreatic cancer…”
Get full text
Journal Article -
13
LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (01-09-2020)“…Studies have found that LncRNA CYTOR is an important regulator of cancer. However, the function of lncRNA CYTOR in pancreatic cancer (PC) is unclear. This…”
Get full text
Journal Article -
14
Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-12-2019)“…Hepatocellular carcinoma (HCC) patients have low 5-year survival due to the delayed diagnosis, so it is necessary to develop an alternative treatment…”
Get full text
Journal Article -
15
Light‐activatable multifunctional paclitaxel nanoprodrug for synergistic chemo‐photodynamic therapy in liver cancer
Published in BioFactors (Oxford) (01-07-2022)“…Paclitaxel (Ptx) is widely utilized to treat liver cancer, and the treatment benefit of reactive oxygen species (ROS)‐responsive Ptx nanoprodrug is…”
Get full text
Journal Article -
16
EIF3B promotes cancer progression in pancreatic cancer
Published in Scandinavian journal of gastroenterology (04-03-2021)“…This study aimed to analyze the relative expression of Eukaryotic Translation Initiation Factor 3 Subunit B (EIF3B) in pancreatic cancer and elucidate its…”
Get full text
Journal Article -
17
Resección radical selectiva para el cáncer de páncreas irresecable
Published in Cirugia y cirujanos (03-03-2022)Get full text
Journal Article